SHANNON RESETICH is head of North America for rare diseases and rare blood disorders for Sanofi Genzyme. She is dedicated to inclusion, diversity, and gender parity and has held global leadership positions for the past five years with Healthcare Businesswomen’s Association (HBA). Prior to joining Sanofi, Resetich served as a board director, EVP, & chief commercial officer for Activcore, a global franchise head of hematology for Shire. Prior to the Shire acquisition of Baxalta, she held multiple positions of increasing responsibility to advance standards of care for rare hematology and rare pulmonology patients with Baxter/Baxalta. Additionally, she spent multiple years in R&D and brand development with Kraft Foods and held marketing leadership roles with TAP Pharmaceuticals. Shannon received her MBA from the Kellogg School of Management at Northwestern University and earned her undergraduate degree from Purdue University in biological engineering.